# 内源性动静脉瘘设备市场

> EndoAVF设备市场研究报告按类型（外周EndoAVF设备、中央EndoAVF设备、混合EndoAVF设备）、按应用（血液透析、移植、肿瘤学）、按最终用户（医院、门诊手术中心、透析中心）、按程序类型（选择性程序、紧急程序、门诊程序）和按地区（北美、欧洲、南美、亚太、中东和非洲） - 增长与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.04%
- **2024:** $ 0.99 Billion
- **2025:** $ 1.05 Billion
- **2035:** $ 1.89 Billion
- **Key Players:** Endologix (US), Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Teleflex Incorporated (US), Cook Medical (US), Cardinal Health (US)

**Report ID:** MRFR/HC/36826-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** October 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/endoavf-device-market-38805

---

## Market Summary

## **EndoAVF Device Market Overview**

As per MRFR analysis, the EndoAVF Device Market Size was estimated at 0.99 (USD Billion) in 2024. The EndoAVF Device Market Industry is expected to grow from 1.05 (USD Billion) in 2025 to 1.78 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.04% during the forecast period (2025 - 2034).

### **Key EndoAVF Device Market Trends Highlighted**

The EndoAVF Device Market is largely driven by the increasing prevalence of chronic kidney disease and the growing number of patients requiring hemodialysis. As healthcare providers look for efficient solutions, the focus shifts towards improving patient outcomes through advanced technologies in vascular access. The rising awareness about the benefits of endovascular arteriovenous fistulas compared to traditional methods is also fueling market growth. Technological advancements and innovations in medical devices are making these procedures more accessible and safer for patients, which in turn supports broader market expansion. There are numerous opportunities to be explored within this market.

As research continues to evolve, manufacturers can tap into the potential for developing next-generation devices that enhance functionality and adaptability to various patient needs. Collaborations among medical device companies, healthcare providers, and research institutions can lead to innovative solutions. Enhanced education and awareness programs can also create more informed patients who understand their options for vascular access.

The growing emphasis on patient-centric approaches in healthcare opens the avenue for personalized solutions in endoAVF devices. Recently, trends in this market indicate a shift towards minimally invasive techniques and greater incorporation of robotic and digital technologies.The increasing integration of telemedicine is also changing how patients manage their conditions, allowing for remote follow-ups and monitoring, thereby enhancing overall care.

The growing demand for home-based therapies specifically within nephrology, is encouraging further innovation in endoAVF devices. As the healthcare landscape changes, these trends signal a move towards more flexible and patient-friendly solutions that meet the evolving needs of chronic disease management.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **EndoAVF Device Market Drivers**

### Increasing Prevalence of Chronic Kidney Diseases

Significant growth rates are observed in the EndoAVF Device Market Industry owing to the increasing number of chronic kidney disease (CKD) cases across the globe. There is an increasing number of CKD patients who are diagnosed, and because of this, a greater need for effective treatment is witnessed, more so in cases where the administrating hemodialysis requires repeated access to blood vessels. These endoAVF devices address the major challenge of the creation of arteriovenous fistulas in a robust and patient friendly manner.

In addition, the elderly segment is likely to report an increased prevalence of CKD, and this has made the old population a more critical factor. Indeed, with developing healthcare infrastructure and growing awareness related to the issues of the kidney, endoAVF devices are being utilized by health care services. This shift in trend is likely to positively influence the growth of the EndoAVF Device Market Industry as it provides new solutions that meet the demand of patients undergoing dialysis for longer periods of time and also eliminates many problems of conventional vascular access methods.

### Technological Advancements in Medical Devices

Technological advancements are driving the EndoAVF Device Market Industry forward, with innovations leading to the development of more effective and user-friendly devices. Continuous research and development efforts have given rise to next-generation endoAVF devices featuring enhanced biocompatibility and reduced surgical risks. These advancements make procedures smoother and improve patient outcomes, thereby increasing their acceptance among physicians and patients alike.Enhanced imaging techniques also allow for better procedural precision, further driving the adoption of endoAVF devices.

### Government Initiatives and Support for Kidney Health

Government initiatives aimed at promoting kidney health and offering better healthcare access contribute significantly to the growth of the EndoAVF Device Market Industry. Many countries are implementing programs focused on dialysis treatment and preventive healthcare measures for CKD. By providing favorable reimbursement policies and funding for research on effective treatment methods, these initiatives encourage healthcare facilities to invest in advanced endoAVF devices, ultimately benefiting patients in need of vascular access for dialysis.

## **EndoAVF Device Market Segment Insights**

### **EndoAVF Device Market Type Insights**

The EndoAVF Device Market reveals a nuanced landscape segmented by Type, showcasing the framework essential to comprehending market dynamics. In the year 2023, the market is valued at 0.89 USD Billion, reflecting a burgeoning interest in endovascular access for arteriovenous fistulas. The segmentation of this market primarily encompasses Peripheral EndoAVF Devices, Central EndoAVF Devices, and Hybrid EndoAVF Devices, each contributing uniquely to the overall valuation and growth trajectory.

The Peripheral EndoAVF Devices hold significant ground in this arena, with a valuation of 0.34 USD Billion in 2023 and anticipated growth leading to a valuation of 0.57 USD Billion by 2032, representing a majority holding within the market.

Its relevance lies in its broad applications in vascular access for hemodialysis, catering to an ever-increasing patient population with end-stage renal disease. Following closely, Central EndoAVF Devices maintain a substantial foothold, valued at 0.30 USD Billion in 2023, with projections reaching 0.51 USD Billion by 2032. These devices are vital due to their effectiveness in providing stable vascular access, underlining their significance in complex clinical scenarios.

Meanwhile, Hybrid EndoAVF Devices, although currently the smallest segment valued at 0.25 USD Billion in 2023, are expected to grow to 0.42 USD Billion by 2032.This growth signals a rising interest in technologies that combine different methodologies to optimize patient care. Analyzing these dynamics not only presents a clear picture of the EndoAVF Device Market revenue distribution but also illustrates the underlying trends and drivers of market growth, such as technology advancement, an aging population, and an increase in chronic diseases.

The interplay of these segments reflects a broader industry shift towards more effective and accessible treatment options poised to meet increasing healthcare demands globally.Thus, the market statistics underscore opportunities for innovation within these segments, driving future research and development.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **EndoAVF Device Market Application Insights  **

The EndoAVF Device Market in 2023 was valued at 0.89 billion USD, demonstrating robust growth potential in the application segment, which includes Hemodialysis, Transplantation, and Oncology. Among these applications, Hemodialysis remains a vital area due to the increasing prevalence of chronic kidney diseases, necessitating the development and use of reliable vascular access devices. Transplantation has emerged as a significant segment as advancements in techniques and technologies enhance patient outcomes, making it a preferred choice for end-stage renal disease management.

Oncology also plays a crucial role as the demand for vascular access devices increases to support chemotherapy treatments. The EndoAVF Device Market segmentation indicates a diverse landscape that caters to various medical needs, reflecting the critical nature of these applications in modern healthcare. As the market evolves, drivers like technological advancements and a growing patient population will shape trends, while challenges such as regulatory hurdles and competition may necessitate continued innovation. Together, these factors contribute to a dynamic and growing market with significant opportunities for development across all applications.

### **EndoAVF Device Market End User Insights  **

The EndoAVF Device Market, valued at 0.89 billion USD in 2023, is witnessing significant growth influenced by its diverse End User segment. This market is primarily segmented into key areas including hospitals, ambulatory surgical centers, and dialysis centers, each playing a crucial role in the adoption and utilization of EndoAVF devices. Hospitals dominate this segment, benefiting from advanced infrastructure and specialized staff, which facilitates complex vascular access procedures.

Ambulatory surgical centers are emerging as essential alternatives, offering efficient outpatient services that align with the growing trend toward minimally invasive surgical practices.Dialysis centers are also pivotal as they require reliable vascular access solutions for patients. The increasing prevalence of renal diseases and the rising demand for effective dialysis treatments further enhance the significance of dialysis centers within this market.

The EndoAVF Device Market data suggests that each of these End Users contributes to the market growth by addressing specific healthcare needs and improving patient outcomes, thus providing opportunities to innovate and expand their services. Moreover, market trends reveal a steady shift towards integrated treatment solutions, which are anticipated to bolster the overall market dynamics in the coming years.

### **EndoAVF Device Market Procedure Type Insights  **

The EndoAVF Device Market is forecasted to reach a valuation of 0.89 billion USD in 2023, reflecting steady demand in the healthcare sector. Within this market, the Procedure Type segment is a crucial area of focus, consisting of various categories. Elective Procedures are often noted for their planned nature and play a key role in enhancing patient quality of life, hence driving the market growth.

Emergency Procedures address critical situations and underline the medical urgency in utilizing EndoAVF devices. Outpatient Procedures, which facilitate shorter hospital stays, are gaining traction due to their efficiency and convenience, presenting significant opportunities for market expansion.The collective growth of these categories shapes the overall dynamics of the EndoAVF Device Market, with each type serving distinct patient needs and clinical requirements.

As the market evolves, understanding the EndoAVF Device Market segmentation will be vital for stakeholders aiming to capture market share and address the varying demands of healthcare providers and patients. Overall, these segments contribute actively to the EndoAVF Device Market revenue and are instrumental in meeting the rising demand for innovative vascular access solutions.

### **EndoAVF Device Market Regional Insights  **

The EndoAVF Device Market demonstrates significant regional segmentation, where in 2023, North America holds the majority with a valuation of 0.45 USD Billion, projected to rise to 0.75 USD Billion by 2032. This dominance is attributed to advanced healthcare infrastructure and a higher adoption rate of innovative medical devices. Europe follows, with a market value of 0.25 USD Billion in 2023, increasing to 0.4 USD Billion by 2032, driven by a growing geriatric population and increasing awareness about vascular access solutions.

The APAC region, valued at 0.12 USD Billion in 2023, is anticipated to exhibit robust growth as healthcare investments rise, with projections reaching 0.22 USD Billion by 2032.South America's market is smaller at 0.05 USD Billion in 2023, expected to grow to 0.08 USD Billion, reflecting its emerging healthcare landscape. Lastly, the MEA region, valued at 0.02 USD Billion in 2023, is limited but holds growth potential as healthcare systems develop, projected to reach 0.05 USD Billion by 2032.

Overall, the EndoAVF Device Market illustrates diverse opportunities across regional markets, fueled by varying healthcare dynamics and growing demand for effective vascular access solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **EndoAVF Device Market Key Players and Competitive Insights**

The EndoAVF Device Market is experiencing significant growth driven by advancements in medical technology and an increasing demand for minimally invasive vascular access solutions. This sector is characterized by intense competition among notable manufacturers and innovative startups who are striving to enhance patient outcomes and streamline procedural efficiency. The competitive landscape features a variety of companies that are focused on developing sophisticated devices aimed at facilitating the creation of endovenous arteriovenous fistulas.

As the market matures, factors such as product innovation, regulatory compliance, and strategic partnerships are becoming pivotal in shaping the competitive dynamics. Key players are increasingly investing in research and development to foster technological advancements while navigating the complexities of regulatory approvals across various regions.Terumo Corporation has established a strong presence in the EndoAVF Device Market, recognized for its commitment to quality and innovation. The company leverages its extensive experience in the medical device industry to offer a range of endoAVF products that are designed to improve patient safety and procedural effectiveness.

With a robust research and development framework, Terumo Corporation continually seeks to enhance its offerings, integrating cutting-edge technologies that cater to the evolving needs of healthcare providers. The company's strategic collaborations and partnerships further bolster its market position, enabling it to access diverse distribution channels. Its strong focus on customer relationships ensures that it remains responsive to the requirements of medical professionals and patients alike, thereby solidifying its role as a leader in the endoAVF device market.Stryker is also a key player in the EndoAVF Device Market, known for its focus on medical innovation and high-quality healthcare products.

The company has a wide array of solutions specifically designed to enhance vascular access and improve clinical outcomes. Stryker invests heavily in technology and product development, allowing for advancements that address the complexities of endovenous procedures. The company’s extensive global reach enables it to cater to diverse healthcare markets, ensuring availability and access to its devices across multiple regions. Strong customer support services and training programs further enhance Stryker's reputation among healthcare professionals. The commitment to improving patient outcomes through innovative design and effective solutions positions Stryker as a formidable competitor within the endoAVF device sector.

## **Key Companies in the EndoAVF Device Market Include**

- Terumo Corporation
- Stryker
- Hologic
- Smith and  Nephew
- Cardinal Health
- Teleflex
- Baxter International
- Medline Industries
- AngioDynamics
- Cook Medical
- Bard Medical
- Abbot Laboratories
- Boston Scientific
- **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)**
- Johnson and  Johnson

## **EndoAVF Device Market Industry Developments**

The EndoAVF Device Market has seen noteworthy developments recently, particularly with major companies like Terumo Corporation, Stryker, and Hologic continuing to advance their technologies. Innovations are being introduced that enhance the efficacy of EndoAVF procedures, allowing for better patient outcomes. Companies such as Smith and Nephew and Bard Medical are increasing their presence by launching new products aimed at improving vascular access. In terms of mergers and acquisitions, there have been strategic alignments involving firms like Medtronic and Boston Scientific, indicating a trend toward consolidation to amplify market capabilities and distribution networks.

Furthermore, financial growth is evident within the sector, with an increased market valuation for key players like Baxter International and Teleflex, which is driving further investment and research in endovascular technologies. This surge in market activity is reflective of a broader trend toward minimally invasive procedures, promoting a competitive landscape among companies seeking to capture market share in the EndoAVF device arena. As such, these developments and financial trajectories are shaping the future landscape of the EndoAVF Device Market.

## **EndoAVF Device Market Segmentation Insights**

### **EndoAVF Device Market Type Outlook**

- Peripheral EndoAVF Devices
- Central EndoAVF Devices
- Hybrid EndoAVF Devices

### **EndoAVF Device Market Application Outlook**

- Hemodialysis
- [Transplantation](../../../reports/transplantation-market-11866)
- Oncology

### **EndoAVF Device Market End User Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Dialysis Centers

### **EndoAVF Device Market Procedure Type Outlook**

- Elective Procedures
- Emergency Procedures
- Outpatient Procedures

### **EndoAVF Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Regulatory Focus

监管机构对内血管动静脉瘘设备市场的重视程度不断提高，这影响着市场动态。为了确保内血管设备的安全性和有效性，正在建立更严格的法规和指南。这种监管焦点可能会导致审批过程中的审查力度加大，初期可能会减缓新产品的推出。然而，这也鼓励制造商投资于研究和开发，以满足这些标准。结果是市场上提供的产品更加稳健和可靠。随着合规性成为关键因素，能够有效应对这些监管环境的公司预计将获得竞争优势。这种不断变化的监管环境预计将显著影响内血管动静脉瘘设备市场的未来。

### Growing Patient Population

内血管动静脉瘘设备市场正在见证由日益增长的需要血管通路解决方案的患者群体推动的增长。慢性肾病的流行以及接受透析的患者数量上升正在促成这一趋势。根据最近的统计数据，到2026年，接受透析的患者数量预计将达到500万，创造出对有效的[血管通路设备](https://www.marketresearchfuture.com/reports/vascular-access-device-market-26216)的巨大需求。这个不断增长的患者基础促使医疗服务提供者寻求创新解决方案，从而扩大了内血管动静脉瘘设备的市场。此外，随着对内血管手术益处的认识增加，更多患者可能会选择这些微创选项。因此，内血管动静脉瘘设备市场在适应不断扩大的患者人群需求的同时，预计将实现持续增长。

### Technological Advancements

内血管动静脉瘘设备市场正在经历技术进步的激增，这些进步提高了血管通路手术的有效性和安全性。微创技术和改进的成像技术等创新正在改变内血管动静脉瘘的创建方式。例如，利用超声引导的设备变得越来越普遍，允许更精确的放置并减少并发症。预计市场在未来五年内将以约12%的复合年增长率（CAGR）增长，推动这一增长的正是这些进步。此外，人工智能在设备设计中的整合可能会优化患者结果，使手术更快、更可靠。随着医疗服务提供者寻求采用最新技术，内血管动静脉瘘设备市场准备迎接显著增长。

### Rising Awareness and Education

对血管通路选项的意识和教育的提升正在显著影响内血管动静脉瘘设备市场。医疗专业人员和患者对内血管动静脉瘘相较于传统方法的优势越来越了解。正在实施教育计划和培训项目，以增强对这些设备的理解，从而改善患者结果。随着意识的提高，更多患者可能会倡导内血管动静脉瘘手术，从而推动需求。此外，医疗服务提供者认识到教育其员工掌握最新技术和方法的重要性，这对于成功实施至关重要。这一趋势预计将促进一个更加知情的患者群体，最终有助于内血管动静脉瘘设备市场的扩展，因为它与患者和医疗服务提供者不断变化的需求相一致。

### Increased Investment in Healthcare

对医疗基础设施的投资是内血管动静脉瘘设备市场的关键驱动因素。政府和私人实体正在分配大量资源来改善医疗设施和提升患者护理。这一趋势在医疗系统正在发展以满足老龄化人口需求的地区尤为明显。增加的资金正在促进先进医疗技术的采用，包括内血管动静脉瘘设备，这对于有效的血管通路至关重要。随着医疗服务提供者升级其设施和设备，对创新解决方案的需求可能会增加。此外，科技公司与医疗服务提供者之间的合作变得越来越普遍，促进了尖端设备的发展。这一投资的涌入预计将推动内血管动静脉瘘设备市场向前发展，创造增长和创新的机会。

## Future Outlook

EndoAVF设备市场预计在2025年至2035年间以6.04%的年均增长率增长，受技术进步、血管疾病患病率上升和对微创手术需求增加的推动。

**New opportunities:**

- 开发集成远程医疗平台以进行远程监测和支持。

到2035年，EndoAVF设备市场预计将实现显著增长和创新。

## Segment Insights

### 按类型：外周内瘘设备（最大）与中央内瘘设备（增长最快）

在内瘘设备市场中，外周内瘘设备占据了市场份额的重要部分，使其成为最大的细分市场。它们的广泛采用主要是由于其在增强需要透析患者的血管通路方面的有效性。与此同时，中央内瘘设备正在快速增长，受到技术进步和对微创手术需求增加的推动。由于中央设备能够提供更好的结果和更低的并发症发生率，因此在临床环境中受到青睐。
内瘘设备市场的增长通常受到终末期肾病发病率上升和需要透析的患者数量增加的影响。随着医疗服务提供者旨在改善患者护理，向中央设备的过渡正在加速，因为它们可以简化程序并改善恢复时间。外周设备将继续占主导地位，但由于技术创新和支持其在不同患者群体中使用的良好临床结果，中央设备正在迅速追赶。

外周内瘘设备（主导）与中央内瘘设备（新兴）

外周内瘘设备的特点是能够直接在患者的肢体上创建血管通路，促进更好的血流，使其成为透析治疗的主流。它们的综合设计最小化了与传统通路方法相关的并发症，并为医疗服务提供者提供了额外的便利。另一方面，中央内瘘设备由于能够通过更少的外科干预提供增强的通路而在市场上变得越来越突出。对微创技术的日益重视使中央设备成为一种新兴替代方案，吸引了临床医生和患者，使其成为现代血管通路协议中的可行选择。

### 按应用：血液透析（最大）与移植（增长最快）

在内瘘设备市场中，应用细分展示了在其主要关注领域之间的多样化市场份额，特别是血液透析、移植和肿瘤学。血液透析作为最大的细分市场，因其在管理肾衰竭患者中的关键作用，推动了市场的相当份额。相比之下，移植细分市场正在迅速获得关注，受到移植技术创新和器官移植程序日益普及的推动。

血液透析（主导）与移植（新兴）

血液透析在内瘘设备市场中占据主导地位，原因在于慢性肾病的高发病率以及对有效透析解决方案的相应需求。围绕血液透析治疗建立的强大基础设施和协议确保了其持续的普遍性。另一方面，移植细分市场代表了一个新兴的增长领域。随着医疗技术的进步，器官移植的效率和成功率正在提高，导致其采用率上升。这一增长得到了对器官捐献的认识和接受度提高的进一步支持，使移植成为未来市场发展的关键参与者。

### 按最终用户：医院（最大）与透析中心（增长最快）

内瘘设备市场在关键最终用户细分市场中展示了多样化的分布，医院因其全面的基础设施和高量的手术量而占据了重要份额。门诊外科中心（ASC）作为一个显著的细分市场，提供门诊手术和创新护理模式，而透析中心则迅速成为市场中的关键用户，响应日益普遍的慢性肾病需要先进的血管通路解决方案。

透析中心（新兴）与医院（主导）

医院在内瘘设备市场中仍然是主导力量，受益于广泛的资源、熟练的人员和多样的医疗服务。它们将先进技术整合到患者护理中的能力有助于其更大的市场份额。相比之下，透析中心作为一个关键细分市场正在崛起，受到对专业肾脏护理需求上升的推动。这些中心专注于透析治疗，增加了对高效血管通路的必要性。其增长受到人口变化和透析程序进步的推动，使其成为满足慢性肾病患者独特需求的关键参与者。

### 按程序类型：选择性程序（最大）与紧急程序（增长最快）

内瘘设备市场在其程序类型之间显示出明确的市场份额分布，选择性程序因其计划性和对微创手术选项的日益偏好而占据最大份额。紧急程序虽然份额较小，但由于紧急响应技术的进步和在关键情况下快速干预的需求而正在获得关注。门诊程序虽然重要，但由于对门诊护理的获取差异和患者对舒适和在家恢复的偏好，维持了较小的份额。

选择性程序（主导）与紧急程序（新兴）

选择性程序在内瘘设备市场中占主导地位，关注患者的便利和结果，使医疗服务提供者能够在最佳时间安排手术。这些程序因其选择性特性而具有稳定的需求，迎合寻求高质量护理而不受紧急病例压力的患者。相反，紧急程序正在迅速崛起，受到技术进步和对紧急医疗情况下立即血管通路需求上升的推动。该细分市场的特点是迅速的行动和创新技术，增强了患者的生存和恢复，标志着内血管通路领域的重要趋势。

## Regional Market Share Analysis

### 北美：创新市场的领导者

北美是EndoAVF设备最大的市场，占全球市场份额的约45%。该地区的增长受到终末期肾病的日益普遍、医疗技术的进步和支持性监管框架的推动。对微创手术的需求也在上升，进一步推动市场增长。FDA等监管机构已简化批准流程，增强了市场动态。美国是该市场的主要贡献者，主要参与者如美敦力、波士顿科学和雅培实验室在竞争格局中处于领先地位。先进的医疗基础设施和高额的医疗支出支持了EndoAVF设备的增长。加拿大也在这一市场中发挥着重要作用，随着医疗投资的增加和患者意识的提高，贡献了整体市场。

### 欧洲：具有监管的新兴市场

欧洲是EndoAVF设备的第二大市场，占全球市场份额的约30%。该地区的增长受到老龄化人口、慢性肾病发生率上升和医疗投资增加的推动。欧洲药品管理局（EMA）等监管机构积极推动医疗设备的创新，预计将增强市场的可及性和增长。对以患者为中心的医疗解决方案的关注也是一个重要驱动因素。该地区的主要国家包括德国、法国和英国，医疗系统越来越多地采用先进的医疗技术。B. Braun Melsungen AG和Terumo公司等主要参与者在这些市场中建立了良好的声誉。竞争格局的特点是合作和伙伴关系，旨在增强产品供应和扩大市场覆盖，确保EndoAVF设备的强劲增长轨迹。

### 亚太地区：快速增长和采用

亚太地区的EndoAVF设备市场正在快速增长，占全球市场份额的约20%。该地区的扩展受到医疗支出增加、患者群体增长和对先进医疗技术意识提高的推动。日本和中国等国在这一增长中处于领先地位，政府的倡议旨在改善医疗基础设施和获取创新治疗。对微创手术的需求也在上升，进一步增强了市场潜力。日本在这一市场中脱颖而出，Terumo公司等公司的贡献显著。竞争格局正在演变，本地制造商与成熟的全球参与者并存。该地区对技术进步和患者护理的关注预计将推动EndoAVF设备市场的进一步增长，使其成为投资和发展的关键领域。

### 中东和非洲：医疗保健中的未开发潜力

中东和非洲地区在EndoAVF设备市场中逐渐崭露头角，占全球市场份额的约5%。增长主要受到医疗投资增加、对慢性疾病意识提高和对先进医疗技术需求的推动。南非和阿联酋等国的政府正专注于改善医疗基础设施，这预计将为市场扩展创造机会。该地区多样化的医疗需求为增长提供了独特的环境。南非是该市场的关键参与者，越来越多的医疗设施采用先进的医疗技术。竞争格局的特点是本地和国际参与者的混合，Cook医疗和Cardinal Health等公司正在取得显著进展。随着医疗系统的发展，对EndoAVF设备的需求预计将上升，为该地区的利益相关者提供丰厚的机会。

## Competitive Benchmarking

EndoAVF设备市场目前的特点是动态的竞争格局，受到技术进步和对微创手术需求增加的推动。Endologix（美国）、美敦力（美国）和波士顿科学（美国）等主要参与者处于前沿，各自采用不同的策略以增强其市场存在。Endologix（美国）专注于创新，特别是在开发下一代血管内设备方面，而美敦力（美国）则强调战略合作伙伴关系以扩展其产品供应。波士顿科学（美国）积极追求并购以增强其产品组合，表明市场整合的趋势。总体而言，这些策略促成了一个既创新又快速发展的竞争环境。在商业战术方面，公司越来越多地本地化制造，以降低成本并提高供应链效率。这一方法在EndoAVF设备市场中尤为相关，该市场适度分散，多个参与者争夺市场份额。这些主要参与者的集体影响塑造了市场结构，因为他们利用自身的运营优势获得竞争优势。专注于供应链优化和本地化生产可能会增强对市场需求和监管要求的响应能力。

在8月，Endologix（美国）宣布推出其最新的血管内设备，该设备整合了先进的成像技术以改善手术结果。这一战略举措不仅强化了Endologix对创新的承诺，还使公司能够捕获对复杂血管解决方案日益增长的需求的更大份额。预计这一设备的推出将改善患者结果并简化外科手术，从而巩固Endologix的竞争优势。

在9月，美敦力（美国）与一家领先的远程医疗提供商达成战略合作伙伴关系，以增强其EndoAVF设备的[远程患者监测](https://www.marketresearchfuture.com/reports/remote-patient-monitoring-market-10905)能力。这一合作表明美敦力对数字化转型的关注，旨在通过技术改善患者参与和结果。通过整合远程医疗解决方案，美敦力可能会增强其服务供应，从而在竞争激烈的市场中实现差异化。

在7月，波士顿科学（美国）完成了对一家专注于创新血管技术的小型医疗设备公司的收购。这一收购是扩大波士顿科学产品组合和增强其在EndoAVF设备市场竞争定位的战略举措。新技术的整合预计将推动增长和创新，使波士顿科学能够更好地满足医疗服务提供者和患者不断变化的需求。

截至10月，EndoAVF设备市场正在见证数字化、可持续性和人工智能在产品开发中的整合等趋势。战略联盟日益塑造竞争格局，使公司能够利用互补优势并增强市场供应。展望未来，竞争差异化可能会从传统的基于价格的竞争演变为关注创新、技术进步和供应链可靠性。这一转变强调了在快速变化的市场中保持竞争优势的适应能力和前瞻性战略的重要性。

## Recent News & Developments

EndoAVF设备市场最近出现了显著的发展，特别是Terumo公司、Stryker和Hologic等主要公司继续推进其技术。正在引入的创新提高了EndoAVF手术的有效性，使患者结果更好。Smith and Nephew和Bard Medical等公司通过推出旨在改善血管通路的新产品来增加其市场份额。在并购方面，涉及美敦力和波士顿科学等公司的战略联盟表明了向整合趋势的转变，以增强市场能力和分销网络。

此外，财务增长在该行业中显而易见，Baxter International和Teleflex等主要参与者的市场估值增加，推动了对血管内技术的进一步投资和研究。这一市场活动的激增反映了对微创手术的更广泛趋势，促进了公司之间的竞争格局，寻求在EndoAVF设备领域占据市场份额。因此，这些发展和财务轨迹正在塑造EndoAVF设备市场的未来格局。

## Report Scope

| 2024年市场规模 | 9.897（亿美元） |
| --- | --- |
| 2025年市场规模 | 10.5（亿美元） |
| 2035年市场规模 | 18.87（亿美元） |
| 复合年增长率（CAGR） | 6.04%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | Endologix（美国）、美敦力（美国）、波士顿科学（美国）、Terumo公司（日本）、雅培实验室（美国）、B. Braun Melsungen AG（德国）、Teleflex公司（美国）、Cook医疗（美国）、Cardinal Health（美国） |
| 覆盖的细分市场 | 类型、应用、最终用户、程序类型、区域 |
| 主要市场机会 | 微创技术的进步提高了EndoAVF设备市场的患者结果。 |
| 主要市场动态 | 技术进步和监管变化推动EndoAVF设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太地区、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，EndoAVF设备市场的预计市场估值是多少？**
A: EndoAVF设备市场预计到2035年将达到18.87亿美元的估值。

**Q: 2024年EndoAVF设备市场的市场估值是多少？**
A: 2024年，EndoAVF设备市场的市场估值为9.897亿美元。

**Q: 2025年至2035年EndoAVF设备市场的预期年均增长率是多少？**
A: 在2025年至2035年的预测期内，EndoAVF设备市场的预期年均增长率为6.04%。

**Q: 哪些公司被认为是EndoAVF设备市场的关键参与者？**
A: EndoAVF设备市场的关键参与者包括Endologix、Medtronic、Boston Scientific和Abbott Laboratories。

**Q: EndoAVF设备市场的主要细分市场是什么？**
A: EndoAVF设备市场的主要细分市场包括外周、中央和混合EndoAVF设备。

**Q: 外周EndoAVF设备的估值在2024年至2035年间如何变化？**
A: 外周EndoAVF设备的估值从2024年的3.948亿美元增加到2035年预计的7.435亿美元。

**Q: 哪些应用推动了EndoAVF设备市场的增长？**
A: 推动增长的应用包括血液透析、移植和肿瘤学，其中血液透析的估值从2024年的4.9485亿美元增加。

**Q: 在EndoAVF设备市场中，门诊手术中心的市场表现预期如何？**
A: 门诊手术中心的估值预计将从2024年的2.961亿美元增加到2035年的5.545亿美元。

**Q: 在EndoAVF设备市场中，最常见的手术类型是什么？**
A: EndoAVF设备市场中常见的手术类型包括择期手术、紧急手术和门诊手术。

**Q: 中央EndoAVF设备市场与其他细分市场相比如何？**
A: 中央EndoAVF设备市场预计将从2024年的2.961亿美元增长到2035年的5.545亿美元，显示出强劲的增长。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/endoavf-device-market-38805*